In Re AH Robins Co., Inc.

88 B.R. 742, 1988 U.S. Dist. LEXIS 13738, 1988 WL 79346
CourtDistrict Court, E.D. Virginia
DecidedJuly 26, 1988
DocketBankruptcy 85-01307-R
StatusPublished
Cited by63 cases

This text of 88 B.R. 742 (In Re AH Robins Co., Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re AH Robins Co., Inc., 88 B.R. 742, 1988 U.S. Dist. LEXIS 13738, 1988 WL 79346 (E.D. Va. 1988).

Opinion

MEMORANDUM IN RE CONFIRMATION ORDER

MERHIGE, District Judge, and BLACKWELL N. SHELLEY, Bankruptcy Judge.

On August 21,1985, A.H. Robins Company, Incorporated (“Robins”) filed its petition for reorganization relief pursuant to 11 U.S.C. §§ 101 et seq. (the “Bankruptcy Code”). On that same day, this Court, upon representation that the major aspect of the case required the services of an Article III judge, withdrew the reference of this case to the Bankruptcy Court excepting for limited matters, thus retaining original jurisdiction in the District Court. See Northern Pipeline Co. v. Marathon Pipe Line Co., 458 U.S. 50, 102 S.Ct. 2858, 73 L.Ed.2d 598 (1982).

By agreement, the undersigned, with few exceptions, conducted all proceedings jointly-

During this entire case, despite objections by interested parties, Robins was, pursuant to 11 U.S.C. §§ 1107 and 1108, permitted to and did manage its affairs as debtor-in-possession with monitoring by a court-appointed Examiner.

A full appreciation of the circumstances leading to the Court’s instant consideration of the feasibility of the Debtor’s “Sixth Amended and Restated Plan of Reorganization” in support of its motion for confirmation necessitates a condensed recitation of the events leading both to the petition of August 21, 1985 and to the matter now under consideration.

Background

In June 1970, Robins, a pharmaceutical enterprise, engaged in the research, development, manufacturing, and marketing of prescription drugs and health care products on its own behalf through subsidiaries located both in the United States and in over 100 foreign countries, purchased from the Daikon Corporation an intrauterine birth control device marketed as a Daikon Shield.

The very essence of Robins’ business operations involves major and consistent interaction with doctors, hospitals and other health care providers. The goodwill of individuals and organizations in the profession and business of health care is a major factor in the financial viability of the Debt- or.

Robins and its subsidiaries distributed almost five (5) million Daikon Shields throughout the United States and foreign countries until June, 1974 when the product was withdrawn from the United States market, and early 1975 when foreign sales were discontinued.

By the mid-1970’s, numerous lawsuits alleging injuries associated with the use of the Daikon Shield were filed against Robins, its officers, directors, employees, as well as its insurer, Aetna Casualty and Surety Company (“Aetna”) and various other co-defendants, including hospitals and physicians.

By the time of filing of the instant proceedings, Robins was faced with almost 6,000 lawsuits and claims arising from the Daikon Shield, and had by that period of time, along with Aetna, paid approximately $530 million in settlements or in satisfying judgments arising from Daikon Shield claims.

Additionally, in 1977, Robins and its directors and officers, including William L. Zimmer, III, E. Claiborne Robins and E. Claiborne Robins, Jr., became the subject of a class action suit in 1977 by stockholders Kalman and Anita Ross, based on the alleged dissemination of false and mislead *744 ing information, and failure to disclose other information, concerning the Daikon Shield to purchasers of Robins’ stock during the period of March 8, 1971 through June 28, 1974 (the “Ross Class Action”). The parties to the Ross Class Action agreed upon a settlement in 1984 pursuant to which Robins deposited $6.9 million with its attorneys under an escrow agreement (the “Escrowed Funds”) and submitted the settlement in that amount to the Class Action Court. The Class Action Court had not ruled on the proposed settlement when Robins commenced its reorganization, case on August 21, 1985.

In accord with the Ross Order, this Court authorized named plaintiffs Kalman and Anita Ross to vote as class representatives either acceptance or rejection of the Plan on behalf of the Ross Class Action plaintiffs.

Under the Plan, and to resolve a controversy regarding whether the Escrowed Funds are property of the estate, the claim of the plaintiffs in the Ross Class Action is limited to the Escrowed Funds.

As the Court has indicated, Aetna had been Robins’ insurer covering compensatory damages arising from the use of the Daikon Shield prior to March, 1979.

Robins and Aetna differed as to the extent of the coverage to be afforded Robins under its policy with Aetna, and in 1979 Robins brought suit against Aetna in reference to Aetna’s coverage of Daikon Shield alleged claims (the “Coverage Litigation”). Thereafter, Robins and Aetna entered into a settlement agreement wherein it was agreed that (a) Robins receive $70 million in additional insurance coverage, (b) Aetna would continue to handle and defend Dai-kon Shield cases and claims on Robins’ behalf and (c) certain releases were exchanged.

Aetna has filed in these proceedings a proof of claim seeking from the Debtor reimbursement of approximately $58 million and asserting as well, rights of contribution. Robins, in turn, has contended that it has available to it insurance coverage from Aetna in excess of Aetna’s proof of claim.

The Court directed its Examiner to investigate the amount of insurance coverage available to Robins, including Aetna’s, and to report on the propriety of the settlement between Aetna and Robins in the Coverage Litigation. After a lengthy investigation, the Examiner, Ralph Mabey, a former Bankruptcy Judge, concluded that the settlement of the Coverage Litigation was an arms-length, good faith resolution of the issues involved, and that the amount of the settlement was reasonable as a resolution of the disputed claims.

As the Court has indicated, the consequences of Robins’ Daikon Shield venture were devastating both from a financial aspect as well as from the physical suffering alleged to have resulted to hundreds of thousands of claimants, some of whom have established their claimed injuries as evidenced by a number of judgments rendered against Robins amounting to millions of dollars.

The evidence before the Court is that, immediately prior to the reorganization filing, the financial drain upon Robins’ assets, coupled with declining employee morale and productivity, as well as Robins’ inability to borrow money at a time of a serious cash flow deficiency, led to a late determination to seek protection under the Bankruptcy Code.

Promptly following the filing for reorganization, the Court authorized and approved the appointment of a number of official committees. Each of the committees, with court approval, retained counsel as well as other experts.

The official committees, Equity Security Holders’ Committee, the Unsecured Creditors’ Committee, the Daikon Shield Claimants’ Committee, a Future Claimants’ Representative (collectively, the “Official Committees”), the U.S.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Harrington v. Purdue Pharma L.P. Revisions: 6/27/24
603 U.S. 204 (Supreme Court, 2024)
Harrington v. Purdue Pharma L.P.
603 U.S. 204 (Supreme Court, 2024)
Rohn Industries, Inc. v. Platinum Equity LLC
887 A.2d 983 (Superior Court of Delaware, 2005)
American Home Products Corp. v. Tracy
787 N.E.2d 658 (Ohio Court of Appeals, 2003)
In Re American Family Enterprises
256 B.R. 377 (D. New Jersey, 2000)
Hexcel Corp. v. Stepan Co. (In Re Hexcel Corp.)
239 B.R. 564 (N.D. California, 1999)
King v. Dalkon Shield Trust (In re A.H. Robins Co.)
219 B.R. 161 (E.D. Virginia, 1998)
In Re AH Robins Co., Inc.
216 B.R. 175 (E.D. Virginia, 1997)
Nelson v. Dalkon Shield Trust
216 B.R. 175 (E.D. Virginia, 1997)
In Re Dow Corning Corp.
211 B.R. 545 (E.D. Michigan, 1997)
Bledsoe v. Dalkon Shield Trust
Fourth Circuit, 1997
In Re Robins Company, Incorporated
109 F.3d 965 (Fourth Circuit, 1997)
In Re Hassanally
208 B.R. 46 (Ninth Circuit, 1997)
Dalkon Shield Trust v. Lee
211 B.R. 194 (E.D. Virginia, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
88 B.R. 742, 1988 U.S. Dist. LEXIS 13738, 1988 WL 79346, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-ah-robins-co-inc-vaed-1988.